Form4insider filings, from the source

SEC Form 4 · accession 0001106578-26-000079

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Jun 15, 2026
Accepted (ET)
Jun 16, 2026 · 4:36 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 15, 2026M9,500$146.03A50,013D
Common StockF2Jun 15, 2026S75$538.8484D49,938D
Common StockF3Jun 15, 2026S205$540.4256D49,733D
Common StockF4Jun 15, 2026S200$541.61D49,533D
Common StockF5Jun 15, 2026S440$543.5109D49,093D
Common StockF6Jun 15, 2026S809$545.5071D48,284D
Common StockF7Jun 15, 2026S470$546.2246D47,814D
Common StockF8Jun 15, 2026S482$547.6272D47,332D
Common StockF9Jun 15, 2026S1,459$548.526D45,873D
Common StockF10Jun 15, 2026S732$549.557D45,141D
Common StockF11Jun 15, 2026S1,768$550.7154D43,373D
Common StockF12Jun 15, 2026S1,180$551.5679D42,193D
Common StockF13Jun 15, 2026S760$552.5878D41,433D
Common StockF14Jun 15, 2026S920$553.474D40,513D
Common Stockholding———166Iby Spouse
Common StockF15holding———324,443Iby Trust
Common StockF16holding———249,108Iby Trust
Common StockF17holding———45,596Iby Trust
Common StockF18holding———8,902Iby Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option$146.03Jun 15, 2026M9,500DMar 15, 2020Mar 15, 2027Common Stock9,50031,410D

Explanation of responses